Balance Sheet (USD $)	Jan. 31, 2012	Jul. 31, 2011
Current assets
Cash and cash equivalents	$ 47,400	$ 51,789
Total current assets	47,400	51,789
Other assets
Patents and patent applications (net of accumulated amortizaton)	25,418	25,926
Total assets	72,818	77,715
Liabilities
Accounts payable and accrued liabilities	41,726	104,136
Accrued salaries and wages	100,000	4,127
Due to related party	126,412	307,969
Convertible Notes Payable	100,000
Total liabilities	368,138	416,232
Stockholders' equity (deficit)
Common stock; par value $0.001; 200,000,000 shares authorized; 104,341,333 shares issued and outstanding at January 31, 2012 and 76,976,333 shares issued and outstanding at July 31, 2011	104,341	76,976
Additional paid-in capital	20,405,360	11,092,214
Accumulated deficit during the development stage	(20,805,021)	(11,507,707)
Total stockholders' equity (deficit)	(295,320)	(338,517)
Total liabilities and stockholders' equity(deficit)	$ 72,818	$ 77,715